Entero Therapeutics, Inc. (GRDX) — 10-K/A Filings
All 10-K/A filings from Entero Therapeutics, Inc.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Entero Therapeutics Files 2024 10-K Amendment
— Apr 9, 2025 Risk: medium
Entero Therapeutics, Inc. filed an amendment to its 2024 10-K on April 9, 2025, detailing its financial position as of December 31, 2024. The company, formerly
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX